brain tumor

  • September 6, 2022  

    Brain Tumor Guide Bookmark

    George Lundberg, MD

    The Musella Foundation has announced online availability of the 12th edition of the Brain Tumor Guide for the Newly Diagnosed.

    .

  • April 26, 2022  

    Can Immunotherapy Be Effective for Brain Cancer?

    With: Matt Warner, PhD

    Immunotherapy has reshaped the cancer treatment landscape. This type of treatment boosts the immune system to fight cancer. However, for people with advanced brain cancer, immunotherapy options remain slim. Here, our Curious Dr. George asks Cancer Commons Scientist Matt Warner, PhD, about the challenges and future potential of immunotherapy for brain cancer. Curious Dr. George: An accomplished molecular oncologist, you have now helped many… Read more »

  • January 29, 2021  

    Advice from the Brain Tumor Community Bookmark

    George Lundberg, MD

    NCI-CONNECT shares insights from patients, caregivers, doctors, and advocates with the aim to help you manage your life—regardless of your brain cancer diagnosis.

    .

  • October 1, 2020  

    How an Expert Would Treat His Own Glioblastoma

    With: Al Musella, DPM

    Two years ago, our Curious Dr. George asked Al Musella, DPM, what he would do if he were diagnosed with glioblastoma multiforme (GBM). Here, he revisits that question. Dr. Musella is President of the Musella Foundation For Brain Tumor Research & Information, Inc. Curious Dr. George: You direct an established foundation that supports research and information about brain tumors. What would you do if… Read more »

  • March 9, 2020  

    Facilitating Access to Treatment for Children with Brain Cancer

    With: Leslie Jared, RN, MSN

    A Q&A with Leslie Jared, RN, MSN, Nurse Navigator at Cancer Commons. Email: leslie.jared@cancercommons.org Q: A midline glioma is a type of brain tumor that is particularly dangerous because of its nature and its location in the brain. It often afflicts children. An investigational drug called ONC201 has shown early promise in some patients whose tumors have a specific genetic mutation called H3 K27M.… Read more »

  • February 22, 2020  

    Accelerating Children’s Access to New Treatments for High Risk Brain Tumors Bookmark

    George Lundberg, MD

    Article from Michigan Health Lab curated by Editor in Chief George Lundberg, MD, who notes: 

    Children with serious brain tumors need access to as many clinical trials as possible. This new consortium will encourage that.

    Go to full article published by Michigan Health Lab.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • October 22, 2019  

    Barriers to Accrual and Enrollment in Brain Tumor Trials Bookmark

    George Lundberg, MD

    Research paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Securing participation in clinical trials is a continuing and serious problem of clinical research for many cancers. This paper describes an effort to improve participation for brain cancer clinical trials.

    Go to full article published by Neuro-Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • October 1, 2019  

    Diagnostic Testing for Diffuse Gliomas Bookmark

    George Lundberg, MD

    Announcement from the College of American Pathologists curated by Editor in Chief George Lundberg, MD, who notes: 

    What forms of testing should be done for diffuse gliomas? In this announcement, a global panel invites comments about proposals.

    Go to full announcement published by the College of American Pathologists.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  • September 16, 2019  

    Fixed and Variable Factors that Impact a Brain Tumor Patient’s Prognosis

    George Lundberg, MD

    A Q&A with Burt Nabors, MD, Professor and Director of the Division of Neuro-oncology at the University of Alabama, Birmingham, and a member of the Cancer Commons Brain Tumor Advisory Board; bnabors@uabmc.edu Q: Primary brain gliomas can be devastating, often deadly, malignancies. Obvious prognostic factors include whether they are grade 1, 2, 3, or 4; their extent of growth prior to diagnosis (stage); and… Read more »

  • August 9, 2019  

    Patients with Newly Diagnosed Brain Tumors Bookmark

    George Lundberg, MD

    Curated by Editor in Chief George Lundberg, MD:

    Receiving a brain tumor diagnosis can be shocking for patients and their families. The Musella Foundation’s free “Brain Tumor Guide for the Newly Diagnosed” provides up-to-date guidance for people in this difficult position.

    .